Safety, Tolerability, Efficacy, and Pharmacokinetics of JBT-101 in Systemic Sclerosis
Clinical trial NCT02465437 · TERMINATED
Trial details
- NCT number
- NCT02465437
- Sponsor
- Corbus Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-10-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.